SSA
CBIO

Schonfeld Strategic Advisors’s Crescent Biopharma CBIO Stock Holding History

Schonfeld Strategic Advisors’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-158
Closed -$60K – 1920
2020
Q4 		$60K Buy
+158
New +$55.4K ﹤0.01% 1488
2018
Q3 		– Sell
-1,400
Closed -$2.26M – 880
2018
Q2 		$2.26M Sell
1,400
-996
-42% -$1.71M 0.12% 249
2018
Q1 		$3.89M Sell
2,396
-2,104
-47% -$4.38M 0.29% 99
2017
Q4 		$7.56M Sell
4,500
-501
-10% -$662K 0.62% 29
2017
Q3 		$7M Sell
5,001
-409
-8% -$480K 0.64% 33
2017
Q2 		$6.04M Buy
+5,410
New +$4.47M 0.62% 31

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return